Sébastien Anguille hoofddocent - fundamenteel klinisch navorser Onderzoek Sébastien Anguille Onderzoeksgroep Laboratorium voor Experimentele Hematologie (LEH) Expertise Kanker; hematologische kwaadaardigheden; acute myeloïde leukemie; immuuntherapie; dendritische cellen; genetische gemodifieerde …

Sébastien Anguille hoofddocent - fundamenteel klinisch navorser Publicaties Sébastien Anguille Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives Bron EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099 Auteur(s) Bert Heyrman, Stef Meers, Selim Sid,…

Sébastien Anguille hoofddocent - fundamenteel klinisch navorser Over Sébastien Anguille Sébastien Anguille Afdeling Vaccin & infectieziekten instituut Statuut & functies Bijzonder academisch personeel fundamenteel klinisch navorser Zelfstandig academisch pers. hoofddocent Interne mandaten experte…

Sébastien Anguille hoofddocent - fundamenteel klinisch navorser Onderwijs Sébastien Anguille 2024-2025 2023-2024 2022-2023 2024-2025 Bloed 1 Bloed 1 Studiegidsnr: 1013GENGE2 Bachelor in de geneeskunde Bloed 2 Bloed 2 Studiegidsnr: 2007GENGE1 Master in de geneeskunde Medische celbiologie Medische c…

Sébastien Anguille associate professor - fund. clinical researcher Research Sébastien Anguille Research team Laboratory for Experimental Hematology (LEH) Expertise Cancer; hematological malignancies; acute myeloid leukemia; immunotherapy; dendritic cells; gene-modified T cells including chimeric a…

Sébastien Anguille associate professor - fund. clinical researcher Publications Sébastien Anguille Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives Source EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099 Author(s) Bert Heyrman, Stef Meers, Seli…

Sébastien Anguille associate professor - fund. clinical researcher About Sébastien Anguille Sébastien Anguille Department Vaccine & infectious disease institute Statute & functions Zelfstandig academisch pers. associate professor Bijzonder academisch personeel fund. clinical researcher Internal m…

Sébastien Anguille associate professor - fund. clinical researcher Education Sébastien Anguille 2024-2025 2023-2024 2022-2023 2024-2025 Blood 1 Blood 1 Course code: 1013GENGE2 Bachelor of Medicine Blood 2 Blood 2 Course code: 2007GENGE1 Master of Medicine Medical cell biology Medical cell biology …

Sébastien Anguille associate professor - fund. clinical researcher My website Sébastien Anguille Cookie prreferences Strictly necessary cookies They are necessary for the proper functioning of the website and can not be switched off. They are generally defined only as a result of actions you carry…

Sébastien Anguille associate professor - fund. clinical researcher PhD thesis Sébastien Anguille Overview Full version of PhD thesis Chapter 1 Chapter 1 Supplementary Video Supplementary Table 1 Supplementary Table 2 Cookie prreferences Strictly necessary cookies They are necessary for the proper …

Laboratory of Experimental Hematology search menu search content Movies UAntwerp & UZA [EN] UZA and University of Antwerp: pioneers in immunotherapy [EN] Join our fight against cancer [NL] UZA en UAntwerpen als pioniers in immuuntherapie [NL] Vecht met ons mee tegen kanker 2022 [NL/EN] Prof. Sébast…

Laboratory of Experimental Hematology search menu search content Laboratory of Experimental Hematology LEH The Laboratory of Experimental Hematology (LEH), currently headed by Prof. Sébastien ANGUILLE, is a strong multidisciplinary basic and translational research group. We have a strong national a…

Zwi Berneman emeritus met opdracht Publicaties Zwi Berneman Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Bron Annals of hematology - ISSN 0939-5555- (2024) p. Auteur(s) Sofie Gielis, Donovan Flumens, Sa…

Barbara Stein onbezoldigd medewerker Publicaties Barbara Stein Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron PLoS ONE - ISSN 19…

Zwi Berneman emeritus with assignment Publications Zwi Berneman Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Source Annals of hematology - ISSN 0939-5555- (2024) p. Author(s) Sofie Gielis, Donovan Flume…

Donovan Flumens doctoraatsbursaal Publicaties Donovan Flumens Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Bron Annals of hematology - ISSN 0939-5555- (2024) p. Auteur(s) Sofie Gielis, Donovan Flumens, …

Ann Van de Velde onbezoldigd medewerker Publicaties Ann Van de Velde Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives Bron EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099 Auteur(s) Bert Heyrman, Stef Meers, Selim Sid, Natalie Put, Koen Theunisse…

Barbara Stein unpaid staff Publications Barbara Stein Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ONE - ISSN 1932-6203…

Jolien Van den Bossche onbezoldigd medewerker Publicaties Jolien Van den Bossche Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Bron …

Sanne van der Heijden doctoraatsbursaal Publicaties Sanne van der Heijden Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Bron Annals of hematology - ISSN 0939-5555- (2024) p. Auteur(s) Sofie Gielis, Donov…

Ann Van de Velde unpaid staff Publications Ann Van de Velde Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives Source EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099 Author(s) Bert Heyrman, Stef Meers, Selim Sid, Natalie Put, Koen Theunissen, Koen…

Donovan Flumens doctoral scholarship holder Publications Donovan Flumens Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Source Annals of hematology - ISSN 0939-5555- (2024) p. Author(s) Sofie Gielis, Dono…

Sanne van der Heijden doctoral scholarship holder Publications Sanne van der Heijden Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Source Annals of hematology - ISSN 0939-5555- (2024) p. Author(s) Sofie …

Eva Lion docent - senior onderzoeker Publicaties Eva Lion Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed Bron Annals of hematology - ISSN 0939-5555- (2024) p. Auteur(s) Sofie Gielis, Donovan Flumens, Sann…

Jolien Van den Bossche unpaid staff Publications Jolien Van den Bossche Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study Source PLoS ON…